IOBTQ (IO Biotech) Other Current Receivables: $0.99 Mil (As of Sep. 2025)


What is IO Biotech Other Current Receivables?

IO Biotech IOBTQ +27.50% Other Current Receivables is $0.99 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

IO Biotech's Other Current Receivables for the quarter that ended in Sep. 2025 was $0.99 Mil.

IO Biotech's quarterly Other Current Receivables increased from Mar. 2025 ($0.92 Mil) to Jun. 2025 ($1.14 Mil) but then stayed the same from Jun. 2025 ($1.14 Mil) to Sep. 2025 ($0.99 Mil).

IO Biotech's annual Other Current Receivables declined from Dec. 2022 ($1.53 Mil) to Dec. 2023 ($1.13 Mil) but then increased from Dec. 2023 ($1.13 Mil) to Dec. 2024 ($1.13 Mil).

IO Biotech Other Current Receivables Related Terms

IO Biotech Other Current Receivables Historical Data

* Premium members only.

The historical data trend for IO Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IO Biotech Other Current Receivables Chart

IO Biotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Receivables
Get a 7-Day Free Trial 1.50 2.09 1.53 1.13 1.13

IO Biotech Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.96 1.13 0.92 1.14 0.99

IO Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.99 Mil mean?
IO Biotech (IOBTQ) has a Other Current Receivables of $0.99 Mil as of Sep. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on IO Biotech and its competitors.
Is IO Biotech's Other Current Receivables too high?
IO Biotech's current Other Current Receivables is $0.99 Mil.
How does IO Biotech's Other Current Receivables compare to CNBX and ENDV?
IO Biotech's Other Current Receivables of $0.99 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on IO Biotech and its competitors. IO Biotech's current Other Current Receivables is $0.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IO Biotech stock overvalued right now?
IO Biotech (IOBTQ) has a current Other Current Receivables of $0.99 Mil. The current Other Current Receivables is $0.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For IO Biotech (IOBTQ), the current Other Current Receivables is $0.99 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IO Biotech Business Description

Address Ole Maaloes Vej 3, Copenhagen N, DNK, DK-2200
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.